BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

995 related articles for article (PubMed ID: 17284958)

  • 1. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
    Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
    Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous granular cell tumor with epidermal involvement: a potential mimic of melanocytic neoplasia.
    Ray S; Jukic DM
    J Cutan Pathol; 2007 Feb; 34(2):188-94. PubMed ID: 17244032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic spectrum, immunohistochemical analysis, and clinical features of a series of granular cell tumors of soft tissues: a study from a tertiary referral cancer center.
    Rekhi B; Jambhekar NA
    Ann Diagn Pathol; 2010 Jun; 14(3):162-7. PubMed ID: 20471560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.
    King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE
    Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
    Lazova R; Tantcheva-Poor I; Sigal AC
    J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evaluation of necrotic malignant melanomas.
    Nonaka D; Laser J; Tucker R; Melamed J
    Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck.
    Morris LG; Wen YH; Nonaka D; DeLacure MD; Kutler DI; Huan Y; Wang BY
    Head Neck; 2008 Jun; 30(6):771-5. PubMed ID: 18228523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characteristics of melanoma.
    Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
    J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells.
    Mahmood MN; Lee MW; Linden MD; Nathanson SD; Hornyak TJ; Zarbo RJ
    Mod Pathol; 2002 Dec; 15(12):1288-93. PubMed ID: 12481009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34 expression in primary cutaneous malignant melanoma: apropos of a case and review of the aberrant melanoma phenotype.
    Breza TS; Magro CM
    J Cutan Pathol; 2005 Nov; 32(10):685-9. PubMed ID: 16293181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of S100 protein, alpha-1-antitrypsin, and CD68 in adult and congenital granular cell tumors.
    Filie AC; Lage JM; Azumi N
    Mod Pathol; 1996 Sep; 9(9):888-92. PubMed ID: 8878020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous clear-cell granular cell tumors: the histologic description of an unusual variant.
    Zedek DC; Murphy BA; Shea CR; Hitchcock MG; Reutter JC; White WL
    J Cutan Pathol; 2007 May; 34(5):397-404. PubMed ID: 17448195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nests with numerous SOX10 and MiTF-positive cells in lichenoid inflammation: pseudomelanocytic nests or authentic melanocytic proliferation?
    Silva CY; Goldberg LJ; Mahalingam M; Bhawan J; Wolpowitz D
    J Cutan Pathol; 2011 Oct; 38(10):797-800. PubMed ID: 21812802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous clear cell myomelanocytic tumour: a new member of the growing family of perivascular epithelioid cell tumours (PEComas). Clinicopathological and immunohistochemical analysis of seven cases.
    Mentzel T; Reisshauer S; Rütten A; Hantschke M; Soares de Almeida LM; Kutzner H
    Histopathology; 2005 May; 46(5):498-504. PubMed ID: 15842631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.